Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Tissue inhibitor of metalloproteinase-4 is elevated in early-stage breast cancers with accelerated progression and poor clinical course.

Liss M, Sreedhar N, Keshgegian A, Sauter G, Chernick MR, Prendergast GC, Wallon UM.

Am J Pathol. 2009 Sep;175(3):940-6. doi: 10.2353/ajpath.2009.081094. Epub 2009 Aug 21.

PMID:
19700750
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer.

Schrohl AS, Holten-Andersen MN, Peters HA, Look MP, Meijer-van Gelder ME, Klijn JG, Brünner N, Foekens JA.

Clin Cancer Res. 2004 Apr 1;10(7):2289-98.

PMID:
15073104
[PubMed - indexed for MEDLINE]
Free Article
3.

Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.

Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG.

Mod Pathol. 2007 Jan;20(1):84-9. Epub 2006 Nov 24.

PMID:
17143263
[PubMed - indexed for MEDLINE]
Free Article
4.

Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

Peck AR, Witkiewicz AK, Liu C, Stringer GA, Klimowicz AC, Pequignot E, Freydin B, Tran TH, Yang N, Rosenberg AL, Hooke JA, Kovatich AJ, Nevalainen MT, Shriver CD, Hyslop T, Sauter G, Rimm DL, Magliocco AM, Rui H.

J Clin Oncol. 2011 Jun 20;29(18):2448-58. doi: 10.1200/JCO.2010.30.3552. Epub 2011 May 16.

PMID:
21576635
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.

Wu ZS, Wu Q, Yang JH, Wang HQ, Ding XD, Yang F, Xu XC.

Int J Cancer. 2008 May 1;122(9):2050-6. doi: 10.1002/ijc.23337.

PMID:
18172859
[PubMed - indexed for MEDLINE]
6.

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.

Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE.

Breast Cancer Res. 2009;11(1):R11. doi: 10.1186/bcr2230. Epub 2009 Feb 24.

PMID:
19239686
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.

Liu F, Cui L, Zhang Y, Chen L, Wang Y, Fan Y, Lei T, Gu F, Lang R, Pringle GA, Zhang X, Chen Z, Fu L.

Breast Cancer Res Treat. 2010 Dec;124(3):677-88. doi: 10.1007/s10549-010-0790-6. Epub 2010 Mar 9.

PMID:
20213083
[PubMed - indexed for MEDLINE]
8.

Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.

Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.

Clin Cancer Res. 2003 Nov 1;9(14):5313-7.

PMID:
14614015
[PubMed - indexed for MEDLINE]
Free Article
9.

Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer.

Schrohl AS, Christensen IJ, Pedersen AN, Jensen V, Mouridsen H, Murphy G, Foekens JA, Brunner N, Holten-Andersen MN.

Mol Cell Proteomics. 2003 Mar;2(3):164-72. Epub 2003 Apr 2.

PMID:
12672830
[PubMed - indexed for MEDLINE]
Free Article
10.

The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.

Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi R, Basik M.

Breast Cancer Res Treat. 2006 Jun;97(3):275-83. Epub 2005 Dec 13.

PMID:
16344916
[PubMed - indexed for MEDLINE]
11.
12.

[Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].

Zhang B, Liu YX, Cao WF, Cao XC, Ning LS, Hao XS.

Zhonghua Bing Li Xue Za Zhi. 2008 Jul;37(7):471-6. Chinese.

PMID:
19035119
[PubMed - indexed for MEDLINE]
13.

Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.

Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.

Cancer. 2005 Apr 15;103(8):1676-84.

PMID:
15754326
[PubMed - indexed for MEDLINE]
Free Article
14.

Predictors of early distant metastasis in women with breast cancer.

Rosa Mendoza ES, Moreno E, Caguioa PB.

J Cancer Res Clin Oncol. 2013 Apr;139(4):645-52. doi: 10.1007/s00432-012-1367-z. Epub 2013 Jan 3.

PMID:
23283528
[PubMed - indexed for MEDLINE]
15.

Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.

Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.

Jpn J Clin Oncol. 2005 Mar;35(3):126-33.

PMID:
15741302
[PubMed - indexed for MEDLINE]
Free Article
16.

Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast.

Tsuchiya B, Iwaya K, Kohno N, Kawate T, Akahoshi T, Matsubara O, Mukai K.

Histopathology. 2012 Jul;61(1):69-77. doi: 10.1111/j.1365-2559.2012.04202.x. Epub 2012 Mar 2.

PMID:
22385318
[PubMed - indexed for MEDLINE]
17.

Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.

Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM.

Clin Cancer Res. 2004 Nov 15;10(22):7621-8.

PMID:
15569994
[PubMed - indexed for MEDLINE]
Free Article
18.

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.

Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A; International Breast Cancer Study Group.

Cancer. 2003 Apr 1;97(7):1591-600.

PMID:
12655514
[PubMed - indexed for MEDLINE]
Free Article
19.

The absence of immunoreactivity for tissue inhibitor of metalloproteinase-1 (TIMP-1), but not for TIMP-2, protein is associated with a favorable prognosis in aggressive breast carcinoma.

Kuvaja P, Talvensaari-Mattila A, Pääkkö P, Turpeenniemi-Hujanen T.

Oncology. 2005;68(2-3):196-203. Epub 2005 Jul 4.

PMID:
16006757
[PubMed - indexed for MEDLINE]
20.

Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.

Tvedskov TF.

Dan Med J. 2012 Jul;59(7):B4475. Review.

PMID:
22759850
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk